This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Adverse effects and precautions

Authoring team

  • headache, abdominal pain and diarrhoea are commonly reported by patients taking ezetimibe (1)
  • hypersensitivity reactions have been reported rarely - including angioedema and rash,
  • in comparative studies with ezetimibe plus a statin with a statin alone - the overall incidence of unwanted effects was not significantly different between the groups
    • note however, in one study, 2% of patients randomised to a statin plus ezetimibe developed asymptomatic increases in plasma levels of liver enzymes compared with none of those taking ezetimibe, a statin or placebo alone (1)
  • ...ezetimibe did not appear to reduce the absorption of fat-soluble vitamins (1)
  • no adjustment of the dose of ezetimibe is needed for older patients, patients with renal impairment or those with mild liver dysfunction
    • note however that the manufacturer does not advise the use of ezetimibe in patients with moderate or severe liver disease (Child-Pugh score 7 or more)

Reference:

  1. Drug and Therapeutics Bulletin 2004; 42(9):65-7.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.